Merit Medical Systems INC Form 4 insider transactions
NASDAQ
CEO Fred Lampropoulos reports acquisition and disposal of Merit Medical Systems Inc. stock, including grants of restricted stock units and performance stock units.
NASDAQ
CFO Raul Parra Jr. reports acquisition and disposal of Merit Medical Systems stock, including grants of restricted stock units and performance stock units, as well as shares surrendered for tax obligations.
NASDAQ
Director Thomas James Gunderson reports the acquisition and disposition of Merit Medical Systems (MMSI) stock and stock options.
NASDAQ
Stephen C. Evans, a director at Merit Medical Systems, sold 1,000 shares of common stock at an average price of $76.348 on March 4, 2024.